Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$5.25 USD
+0.32 (6.49%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $5.17 -0.08 (-1.52%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -68.26 | -43.59 | -21.44 | NA | NA |
Depreciation/Amortization & Depletion | -5.01 | 0.29 | 0.59 | NA | NA |
Net Change from Assets/Liabilities | -26.43 | 69.49 | 46.26 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 8.28 | 3.54 | -1.15 | NA | NA |
Net Cash From Operating Activities | -91.41 | 29.72 | 24.26 | NA | NA |
Property & Equipment | -9.81 | -13.98 | -2.90 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 55.55 | -108.22 | -71.41 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | 45.73 | -122.20 | -74.32 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.30 | 239.59 | 9.95 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 29.97 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -3.28 | 0.00 | 0.00 | NA | NA |
Net Cash from Financing Activities | 1.01 | 239.59 | 39.92 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -44.66 | 147.12 | -10.14 | NA | NA |
Cash at Beginning of Period | 190.51 | 43.40 | 53.53 | NA | NA |
Cash at End of Period | 145.85 | 190.51 | 43.40 | NA | NA |
Diluted Net EPS | -20.05 | -12.82 | NA | NA | NA |
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -25.15 | -68.26 | NA | NA |
Depreciation/Amortization & Depletion | NA | 0.02 | -5.01 | NA | NA |
Net Change from Assets/Liabilities | NA | -10.91 | -26.43 | NA | NA |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | NA | NA |
Other Operating Activities | NA | 6.19 | 8.28 | NA | NA |
Net Cash From Operating Activities | NA | -29.85 | -91.41 | NA | NA |
Property & Equipment | NA | -0.92 | -9.81 | NA | NA |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | NA | NA |
Investments | NA | -93.82 | 55.55 | NA | NA |
Other Investing Activities | NA | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | NA | -94.73 | 45.73 | NA | NA |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 86.54 | 4.30 | NA | NA |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | NA | NA |
Other Financing Activities | NA | 0.00 | -3.28 | NA | NA |
Net Cash from Financing Activities | NA | 86.54 | 1.01 | NA | NA |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | NA | -38.05 | -44.66 | NA | NA |
Cash at Beginning of Period | NA | 145.85 | 190.51 | NA | NA |
Cash at End of Period | NA | 107.81 | 145.85 | NA | NA |
Diluted Net EPS | NA | -1.19 | NA | NA | NA |